List of insiders holdings for Syndax Pharmaceuticals Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Domain Partners VI L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE 10% Owner | 2016-03-08 11:47:21 | 1,743,854 0 | 1,743,854 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner | 2023-02-14 11:53:10 | 1,451,197 0 | 1,451,197 | Form 13G |
| Domain Partners VIII L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K 10% Owner | 2021-01-20 19:57:09 | 1,162,554 0 | 1,162,554 | Form 13G |
| ROYSTON IVOR Director | 2017-03-22 13:37:24 | 0 625,545 | 625,545 | Form 4 |
| Metzger Michael A Chief Executive Officer | 2024-02-09 16:05:03 | 378,409 0 | 378,409 | Form 4 |
| Sabus Steve M Chief Commercial Officer | 2022-12-05 16:41:39 | 220,000 0 | 220,000 | Form 4 |
| Podlesak Dennis Director | 2024-02-09 16:04:02 | 141,763 0 | 141,763 | Form 4 |
| Shaw Allan Chief Financial Officer | 2016-03-02 18:06:46 | 137,600 0 | 137,600 | Form 3 |
| Goldan Keith A. Chief Financial Officer | 2024-02-09 16:05:02 | 123,418 0 | 123,418 | Form 4 |
| Gallagher Neil President, Head of R&D | 2024-02-09 16:05:00 | 117,188 0 | 117,188 | Form 4 |
| Madigan Catherine Chief Medical Officer | 2023-02-03 17:01:12 | 110,000 0 | 110,000 | Form 4 |
| Karydas Daphne Chief Financial Officer | 2021-02-05 16:22:19 | 95,000 0 | 95,000 | Form 4 |
| Katkin Keith Director | 2024-02-09 16:04:33 | 65,000 0 | 65,000 | Form 4 |
| Meury William Director | 2024-02-09 16:04:17 | 65,000 0 | 65,000 | Form 4 |
| Legault Pierre Director | 2024-02-09 16:04:00 | 65,000 0 | 65,000 | Form 4 |
| Jarrett Jennifer Director | 2024-02-09 16:04:49 | 65,000 0 | 65,000 | Form 4 |
| Shea Richard P Chief Financial Officer | 2020-02-14 16:37:17 | 53,227 0 | 53,227 | Form 4 |
| Huber Martin H. Jr. Director | 2024-02-09 16:04:51 | 49,000 0 | 49,000 | Form 4 |
| Meyers Michael L. SVP, Chief Medical Officer | 2022-02-03 17:31:53 | 42,344 0 | 42,344 | Form 4 |
| Morrison Briggs Director | 2024-02-09 16:04:08 | 34,836 0 | 34,836 | Form 4 |
| Egros Fabrice Director | 2022-02-03 17:29:44 | 32,000 0 | 32,000 | Form 4 |
| Nolte Alexander Chief Accounting Officer | 2023-02-03 16:58:24 | 17,000 0 | 17,000 | Form 4 |
| Chen Henry Director | 2018-05-25 09:00:25 | 14,000 0 | 14,000 | Form 4 |
| EVNIN LUKE Director 10% Owner | 2018-05-25 09:00:11 | 14,000 0 | 14,000 | Form 4 |
| DP VI Associates L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Director 10% Owner | 2016-03-08 11:52:26 | 13,925 0 | 13,925 | Form 4 |
| DOMAIN ASSOCIATES BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K Kamdar Kim P. Shah Nimesh 10% Owner | 2016-03-02 18:37:27 | 13,564 0 | 13,564 | Form 3 |
| Kamdar Kim P. Director 10% Owner | 2016-11-02 16:44:50 | 8000 0 | 8000 | Form 4 |
| DP VIII Associates L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K 10% Owner | 2016-03-08 11:41:42 | 5641 0 | 5641 | Form 4 |
| Sledge George W. Jr. Director | 2017-05-19 11:27:01 | 5000 0 | 5000 | Form 4 |
| Ordentlich Peter Chief Scientific Officer | 2023-02-17 18:09:58 | 0 0 | 0 | Form 4 |
| MPM BioVentures IV QP LP Scopa James Paul Foley Todd GADICKE ANSBERT KAILIAN VAUGHN M MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM BioVentures IV Strategic Fund L.P. 10% Owner | 2021-02-12 16:06:57 | 0 0 | 0 | Form 13G |